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Abstract Research on neuropeptide function has advanced rapidly, yet there is still no spatio-
temporally resolved method to measure the release of neuropeptides in vivo. Here we introduce
Neuropeptide Release Reporters (NPRRs): novel genetically-encoded sensors with high temporal
resolution and genetic specificity. Using the Drosophila larval neuromuscular junction (NMJ) as a
model, we provide evidence that NPRRs recapitulate the trafficking and packaging of native
neuropeptides, and report stimulation-evoked neuropeptide release events as real-time changes in
fluorescence intensity, with sub-second temporal resolution.
DOI: https://doi.org/10.7554/eLife.46421.001
Introduction
Neuropeptides (NPs) exert an important but complex influence on neural function and behavior
(Ho¨kfelt et al., 2000; Insel and Young, 2000; Na¨ssel and Winther, 2010; Bargmann and Marder,
2013). A major lacuna in the study of NPs is the lack of a method for imaging NP release in vivo,
with subcellular spatial resolution and subsecond temporal resolution. Available techniques for mea-
suring NP release include microdialysis (Kendrick, 1990), antibody-coated microprobes
(Schaible et al., 1990) and GFP-tagged propeptides visualized either by standard fluorescence
microscopy (van den Pol, 2012), or by TIRF imaging of cultured neurons (Xia et al., 2009). In Dro-
sophila, a fusion between rat Atrial Natriuretic Peptide/Factor (ANP/F) and GFP was used to investi-
gate neuropeptide trafficking at the fly neuromuscular junction (NMJ) (Rao et al., 2001). Release
was measured indirectly, as a decrease in ANP-GFP fluorescence intensity at nerve terminals report-
ing residual unreleased peptide, on a time-scale of seconds (Wong et al., 2015). None of these
methods combines NP specificity, genetically addressable cell type-specificity, high temporal resolu-
tion and applicability to in vivo preparations (Supplementary file 1). A major challenge is to develop
a tool that encompasses all these features for direct, robust measurement of NP release in vivo.
Results
Neuropeptides are synthesized as precursors, sorted into dense core vesicles (DCVs), post-transla-
tionally modified and cleaved into active forms prior to release (Taghert and Veenstra, 2003). We
reasoned that an optimal in vivo real-time NP release reporter should include (1) a reporter domain
that reflects the physico-chemical contrast between the intravesicular milieu and the extracellular
space (Figure 1—figure supplement 1A); and (2) a sorting domain that ensures its selective
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trafficking into DCVs (Figure 1—figure supplement 1b). The NP precursor may function as the sort-
ing domain, suggested by studies of DCV fusion using pIAPP-EGFP (Barg et al., 2002) and NPY-
pHluorin (Zhu et al., 2007) in cultured neurons, or ANP-GFP in Drosophila (Rao et al., 2001). We
therefore developed a pipeline to screen various transgenes comprising NP precursors fused at dif-
ferent sites to fluorescent reporters, in adult flies (Figure 1—figure supplement 1B–C). A total of 54
constructs were tested. We found that optimal trafficking was achieved by substituting the reporter
for the NP precursor C-terminal domain that follows the final peptide (Figure 1—figure supplement
1B). In order to maintain covalent linkage with the reporter domain, we removed the dibasic cleav-
age site C-terminal to the final peptide.
The DCV lumen has lower pH and free calcium (pH = 5.5–6.75, [Ca2+]~30 mM) compared to the
extracellular space (pH = 7.3, [Ca2+]~2 mM) (Mitchell et al., 2001; Sturman et al., 2006). These dif-
ferences prompted us to test validated sorting domains in a functional ex vivo screen using either
pH-sensitive fluorescent proteins (Miesenbo¨ck et al., 1998) or genetically-encoded calcium indica-
tors (GECIs) (Tian et al., 2012; Lin and Schnitzer, 2016) (Figure 1—figure supplement 1A–D).
Reporters based on pHluorins (Miesenbo¨ck et al., 1998) did not perform well in our hands, there-
fore we focused on GCaMP6s (Chen et al., 2013). The calcium sensitivity threshold of GCaMP6s is
below the calcium concentration in both DCVs and the extracellular space. However, GCaMP6s fluo-
rescence is quenched in the acidic DCV lumen (Barykina et al., 2016), enabling it to function as a
dual calcium/pH indicator (Figure 1A). These key properties should boost the contrast between
GCaMP6s fluorescence in unreleased vs. released DCVs, potentially allowing us to trace NP release
at the cellular level in vivo.
We sought to test several NP precursor-GCaMP6s fusion proteins, called NPRRs (NeuroPeptide
Release Reporters; unless otherwise indicated all NPRRs refer to fusions with GCaMP6s), in an intact
preparation using electrical stimulation to evoke release. Initially for proof-of-principle experiments,
we used the Drosophila larval NMJ to test NPRRANP, a GCaMP6s fusion with rat ANP (Burke et al.,
1997). NMJ terminals are large, individually identifiable, and easy to image and record. In particular,
boutons on muscle 12/13 are diverse – Type Ib and Type Is boutons contain mostly synaptic vesicles
and few DCVs, while Type III boutons contain an abundance of DCVs but no synaptic vesicles
(Menon et al., 2013); moreover, Type III-specific GAL4 drivers are available (Koon and Budnik,
2012) (Figure 1B).
Expression of NPRRANP pan-neuronally (under the control of nsyb-GAL4) followed by double
immuno-staining for ANP and GCaMP (anti-GFP) indicated that the sorting domain and the reporter
domains showed a similar localization in Type III neurons (Figure 1—figure supplement 2). More-
over, the distribution of NPRRANP overlapped that of Bursicon (Figure 1—figure supplement 3D),
an NP that is endogenously expressed in Type III neurons (Loveall and Deitcher, 2010). Both
GCaMP and Bursicon immunoreactivity were strongest within boutons, consistent with the known
subcellular localization of DCVs (Gorczyca and Budnik, 2006).
Glutamate is the only known canonical neurotransmitter used at the larval NMJ (Menon et al.,
2013). This allowed visualization of the subcellular localization of small synaptic vesicles (SV) by
immuno-staining for vGluT, a vesicular glutamate transporter (Fremeau et al., 2001; Kempf et al.,
2013). In Type Ib neurons (which contain relatively few DCVs relative to SVs [Menon et al., 2013]),
vGluT staining was observed as patches with a dim center, which may reflect clustered SVs, while
NPRRANP immunoreactivity was seen in dispersed, non-overlapping punctae (Figure 1C, a-GFP,
inset). In Type III neurons, NPRRs were strongly expressed but no vGluT immunoreactivity was
detected (Figure 1C). The subcellular distribution of this NPRR in larval NMJ neurons, therefore, is
similar to that of other DCV-targeted markers previously used in this system (Rao et al., 2001;
Shakiryanova et al., 2006), and appears to reflect exclusion from SVs.
The diffraction limit of light microscopy precluded definitive co-localization of NPRRs in DCVs.
Therefore, we employed Immuno-Electron microscopy (Immuno-EM) to investigate the subcellular
localization of NPRRs at the nanometer scale. To maximize antigenicity for Immuno-EM, we gener-
ated constructs that replaced GCaMP6s with GFP (NPRRANP-GFP;). NPRRANP-GFP showed dense label-
ing in association with DCVs (Figure 1D, arrows), where the average number of gold particles/mm2
was substantially and significantly higher than in neighboring bouton cytoplasm (DCV/
Bouton ~ 14.26) (Figure 1E, Supplementary file 2). Taken together, these data indicate that
NPRRANP-GFP is localized to DCVs. By extension, they suggest that NPRRANP-GCaMP6s (which has an
identical structure to NPRRANP-GFP except for the modifications that confer calcium sensitivity) is
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Figure 1. Design and Synaptic Localization of an NPRR. (A) Schematic illustrating the principle of NPRRs (Neuropeptide Release Reporters). NPRR
molecules in the DCV lumen (low pH/low calcium, left) exhibit increased fluorescence when released by fusion into the extracellular space (neutral pH/
high calcium, right). NPRR fluorescent signal is expected to decay following diffusion into the synaptic cleft. New NPRR-containing DCVs are produced
by synthesis and transport from the soma, not by recycling. NP: Neuropeptide. DCV: Dense Core Vesicle. SV: Synaptic Vesicle. (B) Distinct motor
neuron subtypes at the Drosophila NMJ (muscle 12/13) have different proportions of DCVs vs. SVs. The GAL4 driver R57C10-Gal4 (nsyb-GAL4) labels all
subtypes, while R20C11-GAL4 selectively labels only Type III neurons, which lack SVs (‘Type III-GAL4’). Light gray circles, black lines and dark gray
shading represent boutons, inter-bouton intervals and subsynaptic reticulum respectively. The studies in this paper focus on Type Ib neurons and Type
III neurons (in red rectangles). (C) Triple immunolabeling for GFP (green), Bursicon (blue) and vGluT (red), in flies containing nsyb-GAL4 driving UAS-
GCaMP6s (upper), or NPRRANP (lower). Type Ib and Type III boutons are indicated. Scale bar, 5 mm. Inset image (NPRRANP, a-GFP channel) shows
details of puncta distribution of NPRRANP in Type Ib neuron. Scale bar, 2 mm. (D) TEM images of boutons immunolabeled with anti-GFP (5 nm gold
particle-conjugated) to detect nsyb>NPRRANP-GFP, which has an identical structure to NPRRANP, but is a GFP rather than GCaMP6s fusion to improve
antigenicity (see Figure 1—figure supplement 4). Note strong labeling in DCVs (arrows) and the neuronal plasma membrane (arrowheads). Scale bar,
200 nm. Lower panel shows representative images of labeled DCVs. Scale bar,100 nm. (E) Quantification for TEM images in (D).
DOI: https://doi.org/10.7554/eLife.46421.002
The following source data and figure supplements are available for figure 1:
Source data 1. Raw data for Immuno-EM experiments (ANP).
DOI: https://doi.org/10.7554/eLife.46421.007
Source data 1. Raw data for Immunno-EM experiments (control group).
DOI: https://doi.org/10.7554/eLife.46421.008
Figure supplement 1. NPRR screening pipeline.
DOI: https://doi.org/10.7554/eLife.46421.003
Figure supplement 2. Exogeneous neuropeptide ANP dictates the expression pattern of NPRRANP.
DOI: https://doi.org/10.7554/eLife.46421.004
Figure supplement 3. Expression of different reporters in Type III neurons in the larval NMJ.
Figure 1 continued on next page
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similarly packaged in DCVs. While these two reporters show indistinguishable distributions by immu-
nofluorescence (Figure 1—figure supplement 4), we cannot formally exclude that the substitution
of GCaMP for GFP may subtly alter subcellular localization of the NPRR in a manner undetectable by
light microscopy.
To measure the release of NPRRs from DCVs, we next expressed NPRRANP in Type III neurons
using a specific GAL4 driver for these cells (Koon and Budnik, 2012) (Figure 2E and Figure 1—fig-
ure supplement 3D). We delivered 4 trials of 70 Hz electrical stimulation to the nerve bundle, a fre-
quency reported to trigger NP release as measured by ANF-GFP fluorescence decrease (Rao et al.,
2001; Shakiryanova et al., 2006), and used an extracellular calcium concentration that promotes
full fusion mode (Ale´s et al., 1999). This stimulation paradigm produced a relative increase in
Figure 1 continued
DOI: https://doi.org/10.7554/eLife.46421.005
Figure supplement 4. Subcellular distribution of NPRRANP and NPRRANP-GFP.
DOI: https://doi.org/10.7554/eLife.46421.006
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Figure 2. NPRR specifically reports neuropeptide release. (A) Trace from a representative experiment showing changes in NPRRANP fluorescence
intensity (DF/F) in Type III motor neurons at the larval NMJ evoked by electrical stimulation. BG: background. S1-S4: Stimulation trials 1–4. I1-I4: Inter-
stimulation Intervals (ISIs) 1–4. Green line: DF/F averaged across all boutons in the field of view. Gray shading: s.e.m envelope. Red bar: electrical
stimulation trials (70 Hz). The three typical phases of the response are indicated in S4. The peak height of the response on the first trial is
characteristically lower (see also (D)), and may reflect competition with unlabeled DCVs in the readily releasable pool. (B) DF/F traces in control flies
expressing cytoplasmic GCaMP6s in Type III neurons. (C) Integrated NPRRANP DF/F values during trials S1-4 and intervals I1-4. A.U.: arbitrary units.
n = 8. ***, p<0.001. (D) Average NPRRANP DF/F peak heights for trials S1-4. n = 8. *, p<0.05. Plotted values in (C–D) are mean ± s.e.m. (E1–E2)
Representative selection of ROIs (yellow). Details see Materials and methods. Scale bar, 5 mm. (F) NPRRANP DF/F response are abolished in Type III
GAL4>UAS NPRRANP flies bearing UAS-TNT (F1) but not UAS-TNT
imp (F2). (G) Average peak heights of NPRR
ANP
DF/F in combined stimulation trials
(S1-4) from (F). ****, p<0.0001. (H) Average ‘undershoot’, defined as the integrated DF/F during ISIs I1-4 (see (C)). In (C–D) and (G–H).
DOI: https://doi.org/10.7554/eLife.46421.009
The following figure supplements are available for figure 2:
Figure supplement 1. Activation of NPRRANPin situ.
DOI: https://doi.org/10.7554/eLife.46421.010
Figure supplement 2. NPRR specifically reports neuropeptide release.
DOI: https://doi.org/10.7554/eLife.46421.011
Figure supplement 3. Blocking DCV fusion using Tetanus Toxin.
DOI: https://doi.org/10.7554/eLife.46421.012
Ding et al. eLife 2019;8:e46421. DOI: https://doi.org/10.7554/eLife.46421 4 of 15
Tools and resources Neuroscience
NPRRANP fluorescence intensity (DF/F), whose peak magnitude increased across successive trials
(Figure 2A, red bars and 2D; Video 1; Figure 2—figure supplement 1, A1 vs. A7). Responses in
each trial showed a tri-phasic temporal pattern: (1) In the ‘rising’ phase, NPRRANP DF/F peaked 0.5–5
secs after stimulation onset, in contrast to the virtually instantaneous peak seen in positive control
specimens expressing conventional GCaMP6s in Type III neurons (Figure 2A–B). The NPRRANP
latency to peak was similar to the reported DCV fusion latency following depolarization in hippocam-
pal neurons (Xia et al., 2009). This delay is thought to reflect the kinetic difference between calcium
influx and DCV exocytosis due to the loose association between DCVs and calcium channels
(Xia et al., 2009). (2) In the ‘falling’ phase, NPRRANP DF/F began to decline 1–5 s before the termina-
tion of each stimulation trial, presumably reflecting depletion of the available pool of releasable
vesicles. In contrast, GCaMP6s fluorescence did not return to baseline until after stimulation offset
(Figure 2A–B). (3) Finally, unlike GCaMP6s, NPRRANP exhibited an ‘undershoot’ (DF/F below base-
line) during the post-stimulation intervals, followed by a ‘recovering’ phase (Figure 2A; Figures 2C,
I1–4). This undershoot may reflect dilution of released fluorescent NPRR molecules by diffusion into
the synaptic cleft (van den Pol, 2012), while recovery may reflect DCV replenishment in the boutons
from vesicles proximal to the imaged release site.
Because NPRRANP fluorescence was preferentially accumulated within boutons, we asked whether
these regions contributed to DF/F peaks more significantly than the inter-bouton intervals (IBIs). To
do this, we partitioned the processes into boutons and IBI fields (Figure 2—figure supplement 2A),
and compared the DF/F in these regions during stimulation trials. The time-averaged ratio of bou-
ton/IBI DF/F (see Materials and Methods) was significantly higher for NPRRANP than for GCaMP6s,
particularly during later stimulation trials (Figure 2—figure supplement 2B, green bars, S2-4). This
contrast indicates that NPRRANP signals are preferentially observed in boutons, where DCVs are
located, and do not reflect differences in cytoplasmic free Ca2+ levels between these regions as
detected by GCaMP6s.
To test definitively if NPRRANP DF/F signals are dependent upon NP release, we blocked vesicle
fusion at terminals of Type III neurons using expression of tetanus toxin light chain (TNT)
(Sweeney et al., 1995), a protease that cleaves n-synaptobrevin, a v-snare required for DCV fusion
(Figure 2—figure supplement 3) (Xu et al., 1998). As a control, we used impotent TNT (TNTimp), a
reduced activity variant (Sweeney et al., 1995). TNT expression completely abolished stimulation-
induced DF/F increases from NPRRANP, while TNTimp did not (Figure 2F). Further analysis revealed
that both the DF/F peaks and inter-stimulation undershoots were diminished by TNT (Figure 2G–H).
In contrast, neither TNT nor TNTimp affected the
kinetics of GCaMP6s signals in Type III neurons
(Figure 2—figure supplement 2C), which report
cytosolic Ca2+ influx. Taken together, these data
support the idea that NPRRANP signals specifi-
cally reflect DCV release.
ANP is a rat NP that lacks a Drosophila homo-
log (Rao et al., 2001). To determine whether
our method could be applied to detect the
release of a specific, endogenous fly NP, we
tested NPRRdTK, one of 6 different reporter var-
iants we initially generated from the Drosophila
neuropeptide precursor, DTK (Figure 1—figure
supplement 1B). In contrast to ANP which enco-
des a single peptide, DTK yields multiple NP
derivatives (Winther et al., 2003). Light micros-
copy (Figure 3A) and Immuno-EM (Figure 3B,
arrows) confirmed that NPRRdTK, like NPRRANP,
was localized to DCVs (DCV/bouton ~ 22.19,
Figure 3C). Using the Type III-specific GAL4
driver to express NPRRdTK and the same stimula-
tion protocol as used for NPRRANP, the basic tri-
phasic response profile was also observed
(Figure 3D). However, peak heights and baseline
Video 1. Activation of NPRRANPin situ. Representative
video recording of NPRRANP-expressing Type III
neurons at the larval NMJ. In the preparation, the Type
III neuron was stimulated as described in Figure 2A.
DOI: https://doi.org/10.7554/eLife.46421.017
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fluorescence fell progressively with successive stimulation trials (Figure 3E), in contrast to NPRRANP
where the first peak and undershoot were lower (Figure 2C–D). The reason for this difference is cur-
rently unclear.
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Figure 3. Application of the NPRR approach to a Drosophila neuropeptide. (A) Triple immunolabeling for GFP (green), Bursicon (blue) and vGluT (red)
in Type III-GAL4> UAS NPRRdTK flies. Scale bar, 5 mm. (B) TEM images of boutons immunolabeled against GFP (5 nm gold) in nsyb-GAL4>UAS
NPRRdTK-GFP flies. Note strong labeling in DCVs (arrows) and bouton plasma membrane (arrowheads). Scale bar, 200 nm. Lower panel shows
representative images of labeled DCVs. Scale bar,100 nm. (C) Quantification of TEM images in (B). (D) NPRRdTK DF/F curve; stimulation conditions as in
Figure 2A. (E) Average NPRRdTK DF/F peak height above pre-stimulation baseline (corrected; see Materials and methods) for stimulation trials S1-4.
n = 6. **, p<0.01.
DOI: https://doi.org/10.7554/eLife.46421.013
The following source data is available for figure 3:
Source data 1. Raw data for Immuno-EM experiments (dTK).
DOI: https://doi.org/10.7554/eLife.46421.014
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We next investigated the relationship between NPRR signal and stimulation intensity, by deliver-
ing to the Type III neurons a series of low to high frequency electrical stimuli (1–70 Hz;
Levitan et al., 2007) while imaging the nerve terminals. For direct comparison of NPRR responses
across different preparations, we applied a posteriori normalization of fluorescent peaks in each trial
to the highest response obtained among all trials. For both NPRRANP and NPRRdTK (Figure 4A–B),
the peak responses showed a positive correlation with stimulation frequency, analogous to that
observed using cytosolic GCaMP6s (Figure 4C). In Type III neurons, the responses of both NPRRs to
stimulation frequencies < 30 Hz (1,5,10,20 Hz) were not statistically significant from zero. NPRRANP
showed a higher sensitivity to high stimulation frequencies (30 Hz: 18.14%, 50 Hz: 82.40% Normal-
ized peak DF/F), while NPRRdTK showed a higher stimulation threshold and lower sensitivity (30 Hz:
3.57%, 50 Hz: 24.67% Normalized peak DF/F).
We next investigated whether the relatively high stimulation frequency required to observe signif-
icant responses with NPRRs was a function of the reporters, or rather of the cell class in which they
were tested. To do this, we expressed both NPRRs in Type Ib neurons, a class of motor neurons that
contains both SVs and DCVs (Figure 1B, Figure 4D–F), and performed stimulation frequency titra-
tion experiments. Strikingly, in Type Ib neurons, significant increases in DF/F could be observed at
frequencies as low as 10 Hz (Figure 4D,E; NPRRANP @ 20 Hz: 12.50%, NPRRdTK @ 20 Hz: 17.67%
normalized peak DF/F). The reason for the difference in NPRR threshold between Type III and Type
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Figure 4. NPRR reveals distinct cell-type specific peptide release properties. For each preparation, a series of stimulation trials were delivered at
frequencies from 1 Hz to 70 Hz, as indicated. In-stimulation response peaks were normalized to 70 Hz. The normalized peaks of NPRRs or calcium
responses (measured with cytosolic GCaMP6s) were pooled and plotted for both Type III (A-C) and Type Ib (D-F) neurons. Responses were compared
to zero. n = 6–12. n.s., not significant. *, p<0.05. **, p<0.01. ***, p<0.001. ****, p<0.0001.
DOI: https://doi.org/10.7554/eLife.46421.015
The following figure supplement is available for figure 4:
Figure supplement 1. Comparison of NPRR response at 30 and 50 Hz.
DOI: https://doi.org/10.7554/eLife.46421.016
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Ib neurons is unknown, but parallels their difference in GCaMP6s response to electrical stimulation
(Figure 4C vs. Figure 4F).
Notably, although NPRRANP and NPRRdTK presented distinct response profiles in Type III neurons,
their performance in Type Ib neurons was more similar (Figure 4A vs. Figure 4B; cf. Figure 4D vs.
Figure 4E). In summary, the differences in performance we observed between the two NPRRs
appeared to be specific to Type III neurons, and were minor in comparison to the differences in per-
formance of both reporters between the two cell classes. The reason for the differences between
NPRRANP and NPRRdTK sensitivity and kinetics in Type III neurons is unknown but may reflect differ-
ences in how well these reporters compete with the high levels of endogenous neuropeptide (Bursi-
con) for packaging, transport or release.
Discussion
Here we present proof-of-principle for a method to detect the release of different neuropeptides in
intact neural tissue, with subcellular spatial and sub-second temporal resolution. By exploiting the
fluorescent change of GCaMP in response to a shift in pH and [Ca2+], we visualized the release of
neuropeptides by capturing the difference between the intravesicular and extracellular microenviron-
ment. NPRR responses exhibited triphasic kinetics, including rising, falling and recovering phases. In
the falling phase, a post-stimulus ‘undershoot’, was observed in which the fluorescent intensity fell
below pre-stimulation baseline. This undershoot presumably reflect the slow kinetics of DCV replen-
ishment relative to release.
The molecular mechanisms of NP release are incompletely understood (Xu and Xu, 2008). It is
possible that individual DCVs only unload part of their cargo during stimulation, in which case many
DCVs that underwent fusion may still contain unreleased NPRR molecules following a stimulus pulse.
Although we are convinced that NPRR signals do indeed reflect NP release, due to the presence of
the recovering phase, we cannot formally exclude that unreleased NPRRs may contribute to the sig-
nal change due to their experience of intravesicular [Ca2+]/pH changes that occur during stimulation.
To resolve this issue in the future, an ideal experiment would be to co-express an NPRR together
with a [Ca2+]/pH-invariant NP-reporter fusion. Multiple attempts to generate such fusions with RFP
were unsuccessful, due to cryptic proteolytic cleavage sites in the protein which presumably result in
degradation by DCV proteases during packaging.
To test if NPRRANP DF/F signals are dependent on NP release, we expressed the light chain of
tetanus toxin (TNT), a reagent shown to effectively block NP release in many (McNabb and Truman,
2008; Hentze et al., 2015; Zandawala et al., 2018), if not all (Umezaki et al., 2011), systems. We
observed a striking difference in NPRR kinetics in flies co-expressing TNT vs. its proteolytically inac-
tive ‘impotent’ control form TNTimp (Figure 2F). The strong reduction of NPRR signals by TNT-medi-
ated n-syb cleavage is consistent with the idea that these signals reflect the release of NPRRs from
DCVs.
We have tested the generalizability of the principles used to generate NPRRs by (1) constructing
a surrogate NP reporter NPRRANP as well as a multi-peptide-producing endogenous Drosophila NP
reporter NPRRdTK (Figures 2–3); (2) characterized NPRR signals in response to varying intensities of
electrical stimulation; and (3) recorded NPRR signals in two different classes of NMJ motor neurons
containing DCVs with or without SVs, respectively (Figure 4). These experiments revealed, to our
surprise, that NPRR responses exhibit cell-type specific characteristics (Figure 4). As NPRRs are
applied to other neuropeptides and cell types, a systematic characterization of neuropeptide release
properties in different peptidergic neurons should become possible, furthering our understanding of
neuropeptide biology.
The method described here can, in principle, be extended to an in vivo setting. This would open
the possibility of addressing several important unresolved issues in the study of NP function in vivo.
These include the ‘which’ problem (which neuron(s) release(s) NPs under particular behavioral condi-
tions?); the ‘when’ problem (when do these neurons release NPs relative to a particular behavior or
physiological event?); the ‘where’ problem (are NPs released from axons, dendrites or both?); and
the ‘how’ problem (how is NP release regulated?). The application of NPRRs to measuring NP
release dynamics in awake, freely behaving animals may yield answers to these important long-
standing questions.
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Materials and methods
Key resources table
Reagent type
(species) or resource Designation Source or reference Identifiers
Additional
information
Genetic
reagent
(D. melanogaster)
UAS-NPRRANP (attp2) this paper See Materials
and methods,
subsection Construction
of transgenic animals.
Genetic
reagent
(D. melanogaster)
UAS-NPRRdTK (attp2) this paper Same as above.
Genetic
reagent
(D. melanogaster)
UAS-TNTimp Bloomington
Drosophila
Stock Center
BDSC:28840;
FLYB:FBti0038575;
RRID:BDSC_28840
Flybase symbol: w[*];
P{w[+mC]=UAS TeTxLC.(-)V}A2
Genetic
reagent
(D. melanogaster)
UAS-TNT Bloomington
Drosophila
Stock Center
BDSC:28838;
FLYB:FBti0038527;
RRID:BDSC_28838
Flybase symbol: w[*];
P{w[+mC]=UAS TeTxLC.tnt}G2
Genetic
reagent
(D. melanogaster)
w; +;
UAS-GCaMP6s
(su(Hw)attp1)
Hoopfer et al., 2015
Antibody anti-GFP
(chicken polyclonal)
Aveslab Aveslab: GFP-1020;
RRID:AB_2307313
(1:250:Immuno-EM,
1:1000: IHC)
Antibody anti-ANP
(rabbit polyclonal)
abcam abcam #14348 (1:500)
Fly strains
All experimental flies were reared on a 12/12 hr day-night cycle at 25˚C. Standard chromosomal bal-
ancers and genetic strategies were used for all crosses and for maintaining mutant lines. Detailed
genotypes used are summarized in Supplementary file 3. The following strains were obtained from
Bloomington Stock Center (Indiana University): R20C11-Gal4 (#48887), R57C10-Gal4 (#39171), UAS-
mCD8::GFP (#32185), UAS-TNT (#28838), UAS-TNTimp (#28840). UAS-opGCaMP6s was made by
Barret Pfeiffer (Gerald Rubin’s lab, Janelia Farm) (Hoopfer et al., 2015).
Construction of transgenic animals
All PCR reactions were performed using PrimeSTAR HS DNA polymerase (Takara #R045Q). All con-
structs were verified via DNA sequencing (Laragen).
To construct UAS-NPRRANP, Drosophila codon-optimized ANP and GCaMP6s were synthesized
using gBlocks service (Integrated DNA Technologies), and subcloned into pJFRC7 vector (from
Addgene #26220) (Pfeiffer et al., 2010) using Gibson cloning. UAS-dTK-NPRR is built in a similar
way except the dTK fragment was cloned from the Drosophila brain cDNA. NPRRdTK-GFP and
NPRRANP-GFP were built similarly except Drosophila codon-optimized GFP was used for the subclon-
ing. All the vectors were injected and integrated into attP2 or attp40 sites (Bestgene Inc; see
Supplementary file 3 for attP sites used for each genotype employed).
Expression screening of NPRR candidates
Adult fly brains were dissected in chilled PBS and fixed in 4% formaldehyde for 55 min at room tem-
perature. After three 10 min rinses with PBS, the brains were cleared with Vectashield (#1000, Vec-
torlabs), mounted, and used for native fluorescence measurements. We trace the NPF neuron
somata and arborization as ROIs. We selected regions next to NPF neurons and measured its fluo-
rescent intensity as a reference, which represents background autofluorescence. Candidates whose
fluorescence reached at least 2-fold higher than reference were selected for functional screening.
Functional screening of NPRR candidates
For the baseline fluorescence measurement, we crossed NPF-Gal4 to the candidate lines and gener-
ated NPF-Gal4>NPRRx (x = candidate label) flies for tests. The dissected adult fly brains were
mounted on a petri dish and immersed in Drosophila imaging saline (108 mM NaCl, 5 mM KCl, 2
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mM CaCl2, 8.2 mM MgCl2, 4 mM NaHCO3, 1 mM NaH2PO4, 5 mM trehalose, 10 mM sucrose, 5 mM
HEPES, pH 7.5). To deliver high potassium challenge, High-K imaging saline was perfused (43 mM
NaCl, 70 mM KCl, 2 mM CaCl2, 8.2 mM MgCl2, 4 mM NaHCO3, 1 mM NaH2PO4, 5 mM trehalose,
10 mM sucrose, 5 mM HEPES, pH 7.5). Live imaging series were acquired using a Fluoview FV3000
Confocal laser scanning biological microscope (Olympus) with a 40, 0.8 N.A. (Numerical Aperture)
water immersion objective (Olympus). Candidates whose post-stimulation fluorescence reached at
least 2-fold of baseline fluorescence (measured as averaged pre-stimulation fluorescence) were
selected for in vivo tests at NMJ. For each candidate line, at least three brains were tested and fold-
change of each was averaged.
Immunohistochemistry
Larval dissection was performed in chilled HL3 solution (70 mM NaCl, 5 mM KCl, 20 mM MgCl2, 10
mM NaHCO3, 115 mM sucrose, 5 mM trehalose, 5 mM HEPES and 1.5 mM CaCl2, pH 7.2). Dis-
sected tissues were fixed in 4% formaldehyde or Bouin’s solution for 30 min at room temperature.
After three 15 min rinses with PBS, tissues were incubated with primary antibodies overnight at 4˚C.
Following three 15 min rinses with PBS, tissues were incubated with secondary antibody for 2 hr at
room temperature. Following three 15 min rinses, tissues were cleared with Vectashield (#1000, Vec-
torlabs) and mounted. Confocal serial optical sections were acquired using a Fluoview FV3000 Con-
focal laser scanning biological microscope (Olympus) with a 60, 1.30 N.A. silicone oil objective
(Olympus). All image processing and analyses were done using ImageJ (National Institute of Health).
The following primary antibodies were used: Chicken anti-GFP (1:250-1:1000, Aveslab #1020),
Rabbit anti-ANP (1:500, abcam #14348), Guinea pig anti-vGluT (Goel and Dickman, 2018) (1:1500),
Rabbit anti-syt1 (Littleton et al., 1993) (1:500) and Rabbit anti-Bursicon (1:2000, a gift from Dr. Ben-
jamin White).
The following secondary antibodies were used: Alexa Fluor 488 Goat anti-Chicken IgY (#A11039,
Invitrogen), Alexa Fluor 488 Goat anti-Rabbit IgG (#A11008, Invitrogen), Alexa Fluor 568 Goat anti-
Rabbit IgG(H + L) (#A11011, Invitrogen), Alexa Fluor 633 Goat anti-Rabbit IgG(H + L) (#A21070, Invi-
trogen), Alexa Fluor 488 Goat anti-Guinea Pig IgG(H + L) (#A11073, Invitrogen), Alexa Fluor 568
Goat anti-Guinea Pig IgG(H + L) (#A11075, Invitrogen), Alexa Fluor 568 Goat anti-Mouse IgG(H + L)
(#A11004, Invitrogen) and Alexa Fluor 633 Goat anti-Mouse IgG(H + L) (#A21050, Invitrogen).
Electron microscopy
Drosophila tissues were fixed in 4% formaldehyde in PBS and stored at 4˚C until preparation by
high-pressure freezing (HPF) and freeze-substitution (FS) (Buser and Walther, 2008; Buser and Dru-
bin, 2013). Tissues were cryoprotected in 2.3 M sucrose for 45 min, transferred to 200 mm deep
planchettes and high-pressure frozen in an EMPact2 with RTS (Leica, Vienna, Austria). FS was carried
out in an AFS2 (Leica, Vienna, Austria) in methanol containing 5% water, 0.05% glutaraldehyde and
0.1% uranyl acetate ( 90˚C, 3 hr;  90 to  80˚C, 10 hr;  80˚C, 4 hr;  80˚C to 4˚C, 24 hr). Samples
were washed once in methanol containing 5% water, infiltrated with hard grade LR White (Electron
Microscopy Sciences, Hatfield, PA, USA) at 4˚C ([LR White]: [methanol containing 5% water] 1:1, 24
hr; 100% LR White, 3  24 hr) and polymerized in a fresh change of LR White using a Pelco BioWave
(Ted Pella, Inc, Redding, CA, USA) set to 750 W, 95˚C for 45 min.
60 nm thin sections (UCT ultramicrotome, Leica, Vienna, Austria) were picked up on formvar-
coated 50 mesh copper grids. The sections were blocked for 3 min in blocking buffer (PBS with 0.5%
bovine serum albumin, which was used for all antibody dilutions), incubated in anti-GFP antibody
(1:500, Aveslab #1020) for 5 min, washed 3 times in blocking buffer, incubated in rabbit anti chicken
antibody (1:50, MP Biomedicals #55302) for 5 min, washed 3 times on blocking buffer, incubated on
protein A - 5 nm gold (1:50, Utrecht, Netherlands), and washed 3 times in PBS and 3 times in dis-
tilled water. The sections were stained in uranyl acetate or uranyl acetate and Reynolds lead citrate
depending on the desired contrast and imaged at 80 kV in a Zeiss EM10C (Zeiss, Oberkochen, Ger-
many) using a CCD camera (Gatan, Pleasanton, CA, USA).
Labeling density was estimated using stereological methods (Griffiths and Hoppeler, 1986).
Cross-sections through boutons were recorded and the following parameters were measured: total
image area, total number of gold particles, number of visible dense core vesicles (DCV), number of
gold particles within a 50 nm radius of the DCV center, bouton area (grid intersection estimate),
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gold within the bouton cytoplasm, gold within 20 nm of the bouton plasma membrane, gold outside
of the bouton (mainly sER). Background labeling was estimated using internal controls (labeling on
blank resin and on muscle fibers) and a biological control (non-GFP expressing genotype). Occa-
sional obvious, large gold aggregates were disregarded. Background was consistently below 0.6
gold/mm2 in independently repeated labeling experiments.
Electrical stimulation
The dissection of third-instar larvae was performed in zero-calcium HL3 saline. The CNS was
removed to avoid spontaneous motor neuron activity. To minimize muscle contraction induced by
electrical stimulation of motor neurons, the larval body walls were slightly stretched and incubated
in HL3 saline supplemented with 10 mM glutamate for 5 mins after dissection to desensitize postsyn-
aptic glutamate receptors. Samples were then shifted to HL3 saline containing 1 mM glutamate and
1.5 mM Ca2+. Motor nerves were sucked into a glass micropipette with a stimulation electrode. In
Figure 2 and Figure 3, to induce maximum dense core vesicle release at type III motor neuron ter-
minals, four repetitive bursts (70 Hz stimulation for 18–20 s with pulse width of 1 ms) with intervals
of 40–42 s were programmed and triggered with a Master-9 stimulator (A.M.P.I., Israel) connected
to an iso-flex pulse stimulator (A.M.P.I., Israel). The stimulation intensity was tested and set to dou-
ble the intensity required to induce muscle contraction by a single pulse stimulation.
In Figure 4, stimulation trials were delivered with the same duration, but with a series of frequen-
cies spanning 1 Hz to 70 Hz.
Calcium imaging
A Nikon A1R confocal microscope with resonant scanner and NIS Element software were used to
acquire live Ca2+ imaging on third instar larvae, bathed with 1 mM glutamate added in 1.5 mM Ca2+
HL3 saline. Type III motor neuron terminals in abdominal segments from A2 to A5 were imaged
using a 60x APO 1.4 N.A. water immersion objective with 488 nm excitation laser. A 5 min period
was used for time-lapse imaging at a resonance frequency of 1 fps (512  512 pixels or 1024  1024
pixels), with z-stacks (step length varying from 1 to 1.5 mm) covering the depth of entire type III
motor neuron terminals. The repetitive electrical stimulation of 70 Hz was delivered during the imag-
ing session. Samples with severe muscle contractions were abandoned due to imaging difficulties.
Maximum intensity projection (MIP) and image registration were conducted using Image J. Plugins
including Image Stabilizer (K. Li, CMU) and Template Matching (Q. Tseng) were used for compensat-
ing drifting and correcting movement induced by electrical stimulations. ROIs were manually
selected by tracing the outer edge of each neuron based on the baseline fluorescence. If the fluores-
cence was too weak to trace, we established a reference stack by empirically adjusting the contrast
on a duplicate of the raw image stack. We used the reference stack for ROI selection and projected
the selected ROIs back onto to the raw image stack for measurement. For frames in which the sam-
ple movement could not be automatically corrected, we manually outlined the ROIs used for meas-
urements. Preparations with severe movement or deformation artifacts were abandoned to avoid
unreliable measurements. Each ROI represent a traceable neuronal branch except Figure 2—figure
supplement 2B, in which the ROIs were further manually partitioned into boutons and IBIs (Inter-
Bouton Intervals) based on morphology. Fluorescence change were normalized to the pre-stimula-
tion background except for Figure 3E, for which the data in each trial was normalized to the average
DF/F during a 5 s period just before stimulation was initiated. No sample size is predetermined
based on statistics. Ca2+ imaging data were acquired from at least six independent NMJs from at
least five animals.
Statistical analysis
Data are presented as mean ± s.e.m. All data analysis was performed with Graphpad Prism 6, Micro-
soft Excel and custom Matlab codes (Source code 1). Mann-Whitney U test was used for comparison
except in Figure 4, where One-sample T test was used for comparison with a specified value (0).
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